ClinicalPredictive value of procalcitonin for intestinal ischemia and/or necrosis in pediatric patients with adhesive small bowel obstruction (ASBO)

PurposeEvaluate serum procalcitonin (PCT) level as a predictor of intestinal ischemia or necrosis (IN) in patients with postoperative adhesive small bowel obstruction (ASBO).MethodsProspective cohort of consecutive patients with ASBO. Patients previously treated with antibiotics or septic were excluded. PCT was measured at the diagnosis of ASBO and every 24 h afterwards. Main outcome: intestinal ischemia or necrosis (IN).ResultsFifty-nine patients were included, 12 of whom were excluded; 47 patients remained in the study; male-to-female ratio = 1.9:1. Management: medical in 15 cases (32%) and surgical in 32 (68%). Main outcome: Intestinal necrosis (IN) in 10 patients (21.3%). Mean PCT level was higher in patients with IN (15.11 ng/ml vs. 0.183 ng/ml, p = 0.002), the proportion of patients with elevated PCT (> 0.5 ng/dl) was higher in patients with IN (70% vs. 8.1%, p =<0.001, RR = 26.4 with a 95% CI of 4.39-159.5). Elevated PCT levels at diagnosis had a 70% positive predictive value (PPV) and 91.8% negative predictive value (NPV) for prediction of IN. With a PCT value at diagnosis of > 1.0 ng/dl, PPV was 87.5% and NPV, 92.3%.ConclusionsPCT levels are closely related to the presence of intestinal ischemia and necrosis in children with ASBO.Level of evidenceStudy of Diagnostic Test, Level II.